AI is about to change healthcare. These 44 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own International General Insurance Holdings, you need to be comfortable with a story built around disciplined underwriting, measured growth and active capital returns, rather than rapid expansion. The latest quarter fits that picture: revenue rose, but net income and EPS fell, which keeps near term earnings momentum as a key question. At the same time, management is holding its higher US$0.075 dividend and has just completed a US$26.33 million buyback, signaling confidence and a willingness to return cash even as profit margins soften. For now, that combination is unlikely to change the core short term catalysts, which still hinge on earnings quality, underwriting results and execution in new markets like India. It does, however, sharpen the focus on how much earnings volatility investors are willing to accept alongside those payouts.
However, this earnings dip raises one risk investors really should not overlook. International General Insurance Holdings' shares have been on the rise but are still potentially undervalued by 30%. Find out what it's worth.Explore another fair value estimate on International General Insurance Holdings - why the stock might be worth just $38.60!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Our top stock finds are flying under the radar-for now. Get in early:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com